NATICK, Mass., Sept. 08, 2016 (GLOBE NEWSWIRE) -- VCANBIO USA Co. Ltd. (VCANBIO USA) and VCANBIO Center for Translational Biotechnology (VCANBIO CTB) today announced that they will host an opening ceremony to celebrate the launch of U.S. operations as subsidiaries of VCANBIO Cell & Engineering Corporation Ltd. (VCANBIO), a company focused on cell therapy and precision medicine.
“Expanding operations into the United States is a momentous occasion for VCANBIO, the largest Chinese biotechnology company and the first company to offer cord blood storage in China,” said Yong Wang, Chairman of VCANBIO USA and VCANBIO Center for Translational Biotechnology. “VCANBIO USA focuses on investing in cell and immunotherapies, while VCANBIO Center for Translational Biotechnology functions as a service entity that fosters partnerships to advance promising new therapies. We are eager to begin building relationships and contributing to the robust biotech community in Massachusetts and the larger United States.”
Following are details of the opening ceremony.
|What:||Ribbon-cutting ceremony, lunch and tour of VCANBIO CTB’s lab|
|Who:||Rep. David P. Linsky (D), State Representative for the 5th Middlesex House District|
|Jijun Xing, the Counselor Consul of Science and Technology Affairs, the Consulate General of the People’s Republic of China in New York|
|Defu Li, Chairman of VCANBIO’s board of directors|
|Yong Wang, Vice Chairman of VCANBIO’s board of directors|
|Dr. MingYuan Wu, Chief Executive Officer of VCANBIO|
|Dr. John Lu, President and Chief Executive Officer of VCANBIO CTB|
|When:||Saturday, September 10, 2016, 11:30 a.m. to 3 p.m.|
|Where:||VCANBIO USA and VCANBIO CTB corporate office|
|21 Strathmore Road|
|Natick, MA 01760|
|RSVP:||If you are a journalist interested in attending the event, please contact Eric Chen at email@example.com.|
The ceremony will continue in the evening with a celebratory dinner at the Museum of Fine Arts in Boston.
About VCANBIO USA and VCANBIO Center for Translational Biotechnology
VCANBIO USA Co. Ltd. and VCANBIO Center for Translational Biotechnology are U.S. subsidiaries owned by VCANBIO Cell & Engineering Corporation Ltd. VCANBIO USA is focused on investing in cell and immunotherapies in North America. VCANBIO CTB is a service entity that identifies promising new therapies at various stages of clinical translation and provides partners with the expertise and resources necessary to efficiently develop the therapies. VCANBIO CTB’s scientific advisory board is comprised of esteemed scientists with expertise in stem cells, hematology, cancer and more. The companies’ corporate offices and labs are located in Natick, MA.
CONTACT: Eric Chen (518) 256-7558 firstname.lastname@example.org
Source:VCANBIO USA Co., Ltd.